Sign in

Matthew Bowler

@mattbowler.bsky.social
338 followers 123 following 17 posts

🇪🇺 🇬🇧 🇺🇸 🇫🇷 scientist, project leader @EMBL @esrfsynchrotron #beamline @ID30_MASSIF1 #kinases #pathogens co-editor 📓 @ActaCrystF opinions my own

PostsRepliesMedia
Reposted by Matthew Bowler
Pierre Maisonneuve @pierre-maisonneuve.bsky.social · 03/09/2026
🧬 Announcing the French Kinase Conference - 1st edition! Nov 9–10, 2026, @iecb.bsky.social We aim to bring together the French community of biologists, structural biologists, and medicinal chemists working on protein kinases. 🔗 fkc2026.sciencesconf.org #Kinases #cellsignaling #DrugDiscovery
143
Reposted by Matthew Bowler
Mohamed-Ali HAKIMI @hakimi.bsky.social · 25/08/2026
Toxoplasma didn't inherit SAGA from us 🧬 it rebuilt it from a 🌱 plant blueprint. Evolution loves a remix. Huge congrats to Dominique Cannella, an outstanding CNRS assistant engineer et al. www.nature.com/articles/s41... @cnrsbiologie.bsky.social @inserm.fr @agencerecherche.bsky.social
nature.com
Divergent SAGA complexes shape the Toxoplasma transcriptome for lytic cycle progression and host interaction - Nature Communications
Researchers show that the zoonotic parasite Toxoplasma gondii built a unique chromatin modifying complex to activate the genes that drive infection and virulence, revealing a potential weak spot for n...
174
Reposted by Matthew Bowler
Belen Pachano @belenpachano.bsky.social · 25/08/2026
Excited to share our new work in @natcomms.nature.com on GCN5b in Toxoplasma gondii! 🧬🦠 Huge thanks to everyone who contributed to this work! Specially Dominique and the amazing @hakimi.bsky.social 🎉 www.nature.com/articles/s41...
nature.com
Divergent SAGA complexes shape the Toxoplasma transcriptome for lytic cycle progression and host interaction - Nature Communications
Researchers show that the zoonotic parasite Toxoplasma gondii built a unique chromatin modifying complex to activate the genes that drive infection and virulence, revealing a potential weak spot for n...
085
Reposted by Matthew Bowler
EMBL @embl.org · 29/06/2026
What happens when AI and biology accelerate each other? EMBL Acting Head of AI Centre, Oliver Stegle, discusses how closer integration of these fields could transform the life sciences. Watch this video to learn more. #EMBL_AI
053
Reposted by Matthew Bowler
Science X / Phys.org @sciencex.bsky.social · 23/06/2026
An automated cryo-EM sample-prep workflow achieved a sevenfold improvement in vitrification quality inside large human cell nuclei versus traditional plunge-freezing. It also screens grids before microscope time is used. doi.org/hb8jvv
phys.org
Unique instruments automate sample preparation, quality control for cryo-electron microscopy
Cryo-electron microscopy (cryo-EM) can help scientists determine the three-dimensional structure of proteins in unprecedented detail.
062
Reposted by Matthew Bowler
EMBL @embl.org · 23/06/2026
The Papp team has developed EasyGrid and EasyGrid Control, new instruments for automated cryo-EM sample preparation and quality control. These systems, recently described in the journal Nature Methods, are improving and accelerating microscopy and imaging studies. bit.ly/4wbhj3L
1126
Matthew Bowler @mattbowler.bsky.social · 16/06/2026
Such a pleasure to see stellar PhD student Jill Von Velsen present and defend her thesis yesterday on the MEK1-ERK2 complex 👉 www.biorxiv.org/content/10.6... Many thanks to the Jury @pierre-maisonneuve.bsky.social Katia Zanier Malene Jensen Gilles Labesse and Franck Fieschi @embl.org
150
Matthew Bowler @mattbowler.bsky.social · 03/06/2026
This was a game changer for our 88 kDa kinase complex www.biorxiv.org/content/10.6...
biorxiv.org
0143
Reposted by Matthew Bowler
Oli Clarke @olibclarke.bsky.social · 27/03/2026
Added a little script to chimerax-trimmings to automate the creation of panels for model-map fit figures. It zones the map around (by default) 40aa parts of each chain (but doesn't cut in the middle of helices). Saves each as a png, metadata to csv. Saves each view as a scene for tweaking views.
27015
Reposted by Matthew Bowler
Dimitry Tegunov @dtegunov.bsky.social · 03/05/2026
We're super excited to share MissAlignment: a new ML-based approach to reference-free tilt series alignment, spearheaded by @martenchaillet.bsky.social. We think it's going to make your cryo-ET life a lot better. Preprint: www.biorxiv.org/content/10.6... Code: github.com/warpem/miss-... 🧶 Thread:
6313118
Reposted by Matthew Bowler
Protein Data Bank in Europe (PDBe) @pdbeurope.bsky.social · 27/04/2026
🚨July 21, 2027: PDB Beta Archive replaces current PDB archive. Key updates: • Extended IDs (1ABC → pdb_00001abc). • Only 12-char IDs issued. • Data in PDBx/mmCIF & PDBML only. All PDB users must transition to extended IDs and PDBx/mmCIF. www.wwpdb.org/news/news?ye... #PDB
042
Reposted by Matthew Bowler
Carter Lab @carter-lab.bsky.social · 24/03/2026
Excited to share our work on the structure and function of cytoplasmic lattices within mouse embryos. A collaborative effort with @niakanlab.bsky.social and work led by @kashishsingh.bsky.social and @inaharasimov.bsky.social . It is now out on BioRxiv: www.biorxiv.org/content/10.6...
620684
Reposted by Matthew Bowler
Roland Dunbrack 🏳️‍🌈 @rolanddunbrack.bsky.social · 22/02/2026
Great work from post-doctoral fellow @joanzone.bsky.social: New preprint on identifying active structures of protein kinases -- capable of binding ATP, Mg ions & especially substrates -- +modeling all 437 human catalytic protein kinase domains in their active conformation. doi.org/10.64898/202...
1268
Reposted by Matthew Bowler
MRC Laboratory of Molecular Biology @mrclmb.ac.uk · 24/02/2026
Are you a structural biologist pushing the boundaries of molecular science with an ambitious research programme? Join our Structural Studies Division as a tenure-track Group Leader, with core funding, world-leading facilities & enthusiastic colleagues. Apply by 16 MAR www.nature.com/naturecareer...
Job opening for Research Group Leader in Structural Studies at MRC Laboratory of Molecular Biology, focusing on macromolecular structures.
03648
Reposted by Matthew Bowler
Sjors Scheres @sjorsscheres.bsky.social · 16/02/2026
Please spread the word: the Structural Studies Division @mrclmb.bsky.social is looking for a new tenure-track, independent group leader with an exciting plan in any area of Structural (Molecular & Cell) biology, in discovery biology and/or methods development. 🥳 mrc.tal.net/vx/mobile-0/...
mrc.tal.net
Research Group Leader Tenure Track - Structural Studies - LMB 2775 - Medical Research Council
Location: Cambridge. Vacancy: Research Group Leader Tenure Track - Structural Studies - LMB 2775. Closing Date: 16/03/2026, 23:55
184106
Matthew Bowler @mattbowler.bsky.social · 11/02/2026
One week left to apply - get writing!
010
Reposted by Matthew Bowler
cryoEM papers @cryoempapers.bsky.social · 20/01/2026
Molecular basis of mitogen-activated protein kinase ERK2 activation by its upstream kinase MEK1 www.biorxiv.org/content/10.64898/2026.01.19.700303v1 #cryoEM
042
Reposted by Matthew Bowler
bioRxivpreprint @biorxivpreprint.bsky.social · 20/01/2026
Molecular basis of mitogen-activated protein kinase ERK2 activation by its upstream kinase MEK1 www.biorxiv.org/content/10.64898/20…
021
Reposted by Matthew Bowler
bioRxiv Molecular Biology @biorxiv-molbio.bsky.social · 20/01/2026
Molecular basis of mitogen-activated protein kinase ERK2 activation by its upstream kinase MEK1 www.biorxiv.org/content/10.64898/20…
032
Matthew Bowler @mattbowler.bsky.social · 22/01/2026
New Preprint alert! Excited to share our latest work on the #MAPKinases from stellar PhD student Jill von Velsen. First structures of the MAP2K MEK1 activating its substrate MAPK between 2.9 and 3.6A - amazing resolutions for such a small and mobile complex! www.biorxiv.org/content/10.6...
12811
Reposted by Matthew Bowler
John Rubinstein @johnrubinstein.bsky.social · 09/01/2026
I'm looking forward to speaking at this course (and finally seeing my PhD-labmate @mattbowler.bsky.social's institute in Grenoble)!
061
Reposted by Matthew Bowler
EMBL Events @events.embl.org · 09/01/2026
Are you working on challenging projects in structural biology? #EMBOMacromolecular will highlight the strategic use of cutting-edge protein structure prediction methods, and recent advances in in situ structural biology. Apply by 18 Feb to join us at EMBL Grenoble! 🧬 s.embl.org/mmo26-01-bl
073
Matthew Bowler @mattbowler.bsky.social · 09/01/2026
Very pleased to be on the organizing committee of the EMBO course Structural Characterization of Macromolecular Complexes in 2026! We have a fantastic line up of speakers and tutors, please share widely! 👉apply here: www.embl.org/about/info/c...
0116
Reposted by Matthew Bowler
EMBL Events @events.embl.org · 11/12/2025
Are you working on challenging projects in structural biology? #EMBOMacromolecular will highlight the strategic use of cutting-edge protein structure prediction methods, and recent advances in in situ structural biology. Apply by 18 Feb to join us at EMBL Grenoble! 🧬 s.embl.org/mmo26-01-bl
024
Matthew Bowler @mattbowler.bsky.social · 05/11/2025
Another amazing drug repurposing study from Silvia Diaz Martin Alexandre Bougdour Christopher Swale and @hakimi.bsky.social Very pleased to have supported the structural work on our favorite protein family - the kinases!
010
Reposted by Matthew Bowler
Mohamed-Ali HAKIMI @hakimi.bsky.social · 05/11/2025
Nature Com. now live! 🎉 Silvia’s amazing PhD supervised by Alex “the Greatest” & Christopher’s big-bang contribution. Huge thanks to our stellar team & collaborators. We went fishing in the FDA pond and hooked LY2090314 🎣 Blocks GSK3 🎯in #Toxoplasma & #Crypto www.nature.com/articles/s41...
nature.com
Structural and functional characterization of TgGSK3, a druggable kinase in Toxoplasma gondii - Nature Communications
Researchers identify the cancer drug LY2090314 as a potent inhibitor of Toxoplasma gondii and Cryptosporidium and report the first crystal structure of the parasite kinase TgGSK3 bound to it, validati...
0114
Reposted by Matthew Bowler
Sophie Pedder @sophiepedder.bsky.social · 08/10/2025
For sure, Macron’s troubles are partly of his own making. But there is something immensely sad about a pro-European leader and standard-bearer for the democratic centre ending up with such a political mess
8699
Reposted by Matthew Bowler
Sjors Scheres @sjorsscheres.bsky.social · 21/09/2025
These results are truly impressive! But I do worry that #cryoEM is moving into a phase where progress is made by optimizing parameter settings for black box programs. The devil is often in the details, and I am not sure how this could be implemented in #relion, as stated, without more info.
23610
Reposted by Matthew Bowler
Mohamed-Ali HAKIMI @hakimi.bsky.social · 06/09/2025
Zeus had his Hydra ⚔️, now Toxoplasma has its own. Meet Hydra: not a monster, but a brand-new protein domain. It multimerizes like crazy & rewrites the chromatin landscape 🧬 in Toxoplasma. Our team and colleagues from @embl.org #Grenoble just dropped the preprint 👉 www.biorxiv.org/content/10.1...
12810
Matthew Bowler @mattbowler.bsky.social · 20/08/2025
In our new paper @asbmb.bsky.social JBC we detail our surprising discovery that the MAP2Ks can use ADP to phosphorylate their substrate MAPKs – driven by @paulineJYX @ErikaPellegri13 and @jvonvelsen t.co/spLZbaz5Wk
t.co
https://www.jbc.org/article/S0021-9258(25)02429-9/fulltext
152
Reposted by Matthew Bowler
Belen Pachano @belenpachano.bsky.social · 13/04/2025
Thrilled to share my first paper, now out in @natmicrobiol.nature.com! Huge thanks to my amazing supervisor @hakimi.bsky.social and everyone who contributed to this work! www.nature.com/articles/s41...
nature.com
An ISWI-related chromatin remodeller regulates stage-specific gene expression in Toxoplasma gondii - Nature Microbiology
Toxoplasma gondii evolved two ISWI remodellers, TgSNF2h and TgSNF2L. TgSNF2h forms a complex that insulates active genes, regulates MORC-driven sexual commitment and ensures precise gene expression, s...
24213
Reposted by Matthew Bowler
EMBL @embl.org · 25/04/2025
1/ Today is #WorldMalariaDay. At EMBL, we join the global efforts to control malaria with innovative biological approaches. 👉 Swipe through to discover how scientists at EMBL study the malaria parasite and drive progress in global health. 🔗 Read more: www.embl.org/news/tag/mal...
A visual with blue and green colours with a text saying "World Malaria Day".A visual with blue and green background with a image on the left showing red lights. Bellow the image is shown a photo of a man. On the right a text about malaria and EMBL is presented.A visual with blue and green background with a image on the bottom showing a hand with gloves golding a glass system. In the middle of the image is shown a photo of a woman. At the top a text about malaria and EMBL is presented.A visual with blue and green background saying in the middle "Check out more in EMBL news using #malaria".
1123
Reposted by Matthew Bowler
Gavi @gavirius.bsky.social · 04/02/2025
We are very happy. The Editors of Journal of Applied Crystallography have chosen figures from our article (journals.iucr.org/j/issues/202...) to feature as the cover image for the February 2025 issue. THANKS
051
Matthew Bowler @mattbowler.bsky.social · 04/01/2025
RIP Sine. She hired me as beamline scientist on ID14 @esrfsynchrotron 17 years ago and was a great director putting automation to the fore ultimately leading to @ID30_MASSIF1
040
Reposted by Matthew Bowler
Gavi @gavirius.bsky.social · 24/12/2024
Counter-diffusion studies of human transthyretin: the growth of high-quality crystals for X-ray and neutron crystallography doi.org/10.1107/S160...
doi.org
Counter-diffusion studies of human transthyretin: the growth of high-quality crystals for X-ray and neutron crystallography
X-ray and neutron diffraction studies of human transthyretin crystallized using the non-convective counter-diffusion method provide important insights into crystallization quality relevant for the gro...
044
Reposted by Matthew Bowler
EMBL @embl.org · 18/12/2024
EMBL scientists discovered that dextromethorphan (DXM) may treat lung #fibrosis. 🫁 DXM is an @fda.gov-approved active ingredient in nonprescription cough syrups. This study, published in Science Translational Medicine, shows how this drug may reduce lung scars. 🧪💊 www.embl.org/news/science...
02510
Reposted by Matthew Bowler
ChimeraX @chimerax.ucsf.edu · 13/12/2024
ChimeraX 1.9 has been released and is available now on our website
cgl.ucsf.edu
Download UCSF ChimeraX
0288
Reposted by Matthew Bowler
François Leulier @francoisleulier.bsky.social · 22/11/2024
A top european science job opened to applications: Scientific director @pasteur.fr research.pasteur.fr/en/job/insti...
research.pasteur.fr
The Institut Pasteur is looking for a Scientific Director | Research - Institut Pasteur
02324
Matthew Bowler @mattbowler.bsky.social · 18/11/2024
📢This year marks 10 years of fully automatic data collection @esrfsynchrotron @EMBLGrenoble ! Join us on the 5th Dec to celebrate the technical developments and scientific successes of @ID30_MASSIF1 👉 esrf.fr/home/events/co…
041
Reposted by Matthew Bowler
Martin Walsh @walshdls.bsky.social · 15/11/2024
ok to all synchrotron and cryoEM people out there ...a hastily put together starter pack! go.bsky.app/UThze5z
3206